Skip to content

Clinical and Radiographic Performance of Zirconia Implants (CERALOG PL) Compared to Titanium Implants (CAMLOG PL): A Randomized Prospective Monocentric Clinical Study

Clinical and Radiographic Performance of Zirconia Implants (CERALOG PL) Compared to Titanium Implants (CAMLOG PL): A Randomized Prospective Monocentric Clinical Study - Performance of Zirconia Implants Compared to Titanium Implants: A Randomized Prospective Monocentric Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036739
Enrollment
40
Registered
2025-05-06
Start date
2026-06-16
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Patients receiving Zirconia Implants Group 2: Patients receiving Titanium Implants

Sponsors

ZZMK Carolinum des Geotehe Universität Frankfurt
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Written consent to voluntary participation in the study was obtained prior to study entry. 2. Single-tooth restorations in the partially edentulous mandible and/or maxilla: Single-tooth gaps with sufficient bone to accommodate an implant with a diameter of 3.8 mm, 4.3 mm, or 5.0 mm. 3. Tooth extraction at least 12 weeks prior to implantation. 4. Opposing jaw consisting of natural teeth or fixed restoration. 5. Systemically healthy patients with no contraindications to oral surgery. 6. Informed patients willing to participate in follow-up examinations.

Exclusion criteria

Exclusion criteria: 1. Smokers (>10 cigarettes daily, cigar equivalents, or chewing tobacco). 2. Systemic diseases that could compromise surgical implantation (e.g., uncontrolled diabetes). 3. Uncontrolled parafunctional disorders (e.g., bruxism, teeth grinding, or clenching). 4. Medical conditions that limit the ability to maintain adequate oral hygiene. 5. Conditions or circumstances that, in the opinion of the investigator, could compromise study completion or outcome analysis (e.g., noncompliance or unreliability). 6. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Survival and success rate in % of implants after 6, 12, 36, 48, 60 months.

Secondary

MeasureTime frame
Pink Esthetic Score, White Esthetic Score, patient-reported outcomes (PROMs) Peri-implant tissue health (bleeding on probing; probing depth; mucosal recession; keratinized mucosa; plaque index; and suppuration) 6, 12, 36, 48, 60 months.

Countries

Germany

Contacts

Public ContactAusra Ramanauskaite

Zentrum der Zahn-, Mund- und Kieferheilkunde (Carolinum) der Johann Wolfgang Goethe-Universität Frankfurt am Main Poliklinik für Zahnärztliche Chirurgie

ramanauskaite@med.uni-frankfurt.de+4917624205266

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026